Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine. Read more about Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine.
Quo vadis, my transplant fellow: a discussion of transplant surgery fellowship training activity in the United States and Canada: 1991-1997. Education Committee of the American Society of Transplant Surgeons. Read more about Quo vadis, my transplant fellow: a discussion of transplant surgery fellowship training activity in the United States and Canada: 1991-1997. Education Committee of the American Society of Transplant Surgeons.
Recruitment of engrafted donor cells postnatally into the blood with cytokines after in utero transplantation in mice. Read more about Recruitment of engrafted donor cells postnatally into the blood with cytokines after in utero transplantation in mice.
Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Read more about Retransplantation of patients with severe posttransplant hepatitis B in the first allograft.
A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. Read more about A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database.
Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection. Read more about Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection.
Failure patterns of cryopreserved vein grafts in liver transplantation. Read more about Failure patterns of cryopreserved vein grafts in liver transplantation.
Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy. Read more about Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy.
Fifty-percent partial liver transplantation in the rat. Read more about Fifty-percent partial liver transplantation in the rat.
In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells. Read more about In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
